Depending on the selectivity of salvinorin A for the opioid kappa receptor, this receptor constitutes a potential molecular target for the development of pharmaceuticals used for the study of characteristic features of different perception disorders, including schisophrenia, the Alzheimer's disease and bipolar affective disorder36. The gene discussed is OPRK1; the disease is Alzheimer disease.